Recurrent glioblastoma (GBM) or High-Grade Glioma (HGG) remains one of the most challenging neuro-oncological conditions, with limited survival benefit from conventional therapies. Emerging molecularly targeted approaches, particularly Lutetium-177–based peptide receptor radionuclide therapy (PRRT), are showing promise as innovative strategies for select…
Terbium-161 FAPI Therapy: A New Frontier for Hard-to-Treat Cancers
When cancer comes back after treatment—or doesn’t respond at all—it can feel like the options are running out. But science is moving fast, and a new therapy called Terbium-161 FAPI is offering fresh hope to patients with relapsed or refractory solid…
Actinium-225 PSMA Therapy: A New Hope for Prostate Cancer Patients in India
If you or your loved one is living with advanced prostate cancer and have already tried several treatments like chemotherapy or Lutetium-177 therapy, there’s a new and promising option available: “Actinium-225 PSMA therapy”. What Is Actinium-225 Therapy? This treatment uses a…